Cargando…

DNA methylation intratumor heterogeneity in localized lung adenocarcinomas

Cancers are composed of cells with distinct molecular and phenotypic features within a given tumor, a phenomenon termed intratumor heterogeneity (ITH). Previously, we have demonstrated genomic ITH in localized lung adenocarcinomas; however, the nature of methylation ITH in lung cancers has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quek, Kelly, Li, Jun, Estecio, Marcos, Zhang, Jiexin, Fujimoto, Junya, Roarty, Emily, Little, Latasha, Chow, Chi-Wan, Song, Xingzhi, Behrens, Carmen, Chen, Taiping, William, William N., Swisher, Stephen, Heymach, John, Wistuba, Ignacio, Zhang, Jianhua, Futreal, Andrew, Zhang, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400640/ https://www.ncbi.nlm.nih.gov/pubmed/28423542 http://dx.doi.org/10.18632/oncotarget.15777

Ejemplares similares

Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
por: Chen, Runzhe, et al.
Publicado: (2022)

Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers
por: Corsini, Erin M., et al.
Publicado: (2020)

A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencing
por: Yang, Peng, et al.
Publicado: (2023)

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
por: Tang, Ming, et al.
Publicado: (2021)

Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
por: Dejima, Hitoshi, et al.
Publicado: (2021)

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
por: Hu, Xin, et al.
Publicado: (2019)

Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
por: Hu, Xin, et al.
Publicado: (2021)

Genomic heterogeneity of multiple synchronous lung cancer
por: Liu, Yu, et al.
Publicado: (2016)

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
por: Chen, Ming, et al.
Publicado: (2021)

Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
por: Lee, Won-Chul, et al.
Publicado: (2020)

Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity?
por: Rosen, Jeffrey M, et al.
Publicado: (2014)

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
por: Hu, Xin, et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
por: Parra, Edwin R., et al.
Publicado: (2018)

Comprehensive T cell repertoire characterization of non-small cell lung cancer
por: Reuben, Alexandre, et al.
Publicado: (2020)

Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
por: Mitchell, Kyle G, et al.
Publicado: (2020)

Comparative genomics of high grade neuroendocrine carcinoma of the cervix
por: Hillman, R. Tyler, et al.
Publicado: (2020)

Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma
por: Kwok, Hoi‐Hin, et al.
Publicado: (2023)

Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer
por: Parra, Edwin Roger, et al.
Publicado: (2023)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing
por: Huang, Jin, et al.
Publicado: (2023)

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2018)

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2019)

Distinct T cell receptor repertoire diversity of clinically defined high-grade serous ovarian cancer treatment subgroups
por: Lee, Sanghoon, et al.
Publicado: (2021)

Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin
por: Beird, Hannah C., et al.
Publicado: (2018)

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors
por: Varela, Ignacio, et al.
Publicado: (2017)

Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung
por: Sivakumar, Smruthy, et al.
Publicado: (2019)

Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Intratumoral Heterogeneity in Lung Cancer
por: Lv, Xiaodi, et al.
Publicado: (2023)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
por: Pataer, Apar, et al.
Publicado: (2018)

Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
por: Zechner, Dietmar, et al.
Publicado: (2016)

Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
por: Zhang, Xia, et al.
Publicado: (2020)

Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma
por: Beird, Hannah C., et al.
Publicado: (2023)

MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data
por: Fan, Yu, et al.
Publicado: (2016)

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
por: Gomez, Daniel Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t0g1qos0d70tnq1aftmvkmmg5n